Perilous Approach: Avastin and Sutent Promote Growth of Breast Cancer Stem Cells

 

Avastin

 

(Note: Many patients in Malaysia have been treated with this very expensive drug)

The U.S. Food and Drug Administration recently revoked approval of Avastin for treating breast cancer. The reversal was in response to clinical trials showing that the drug’s benefit was short-lived, with breast cancer patients quickly relapsing and the cancer becoming more invasive and metastatic.

Cancer treatments designed to block the growth of blood vessels were found to increase the number of cancer stem cells in breast tumors in mice, suggesting a possible explanation for why these drugs don’t lead to longer survival, according to a study by researchers at the University of Michigan Comprehensive Cancer Center.

While anti-angiogenic drugs do shrink tumors and slow the time until the cancer progresses, the effect does not last, and the cancer eventually regrows and spreads.

The researchers treated mice with breast cancer using the anti-angiogenesis drugs Avastin (bevacizumab) and Sutent (sunitinib). The researchers found that tumors treated with these drugs developed more cancer stem cells, which fuel a cancer’s growth and spread and are often resistant to standard treatment.

Read more: http://www.med.umich.edu/cic/2012-spring/perilous-approach.html

 

Advertisements

Author: CA Care

In obedience to God's will and counting on His mercies and blessings, and driven by the desire to care for one another, we seek to provide help, direction and relief to those who suffer from cancer.

3 thoughts on “Perilous Approach: Avastin and Sutent Promote Growth of Breast Cancer Stem Cells”

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s